The global ankylosing spondylitis drugs market is forecast to reach USD 8,413.0 Million by 2028, according to a new report by Reports and Data. Ankylosing spondylitis (AS) can be described as a type of arthritis, which is not commonly observed among the patients of arthritis. The condition results in stiffness and pain in the spine. It is a chronic condition, which usually begins with the lower back. However, it can also spread up the neck or damage other joints in the body. In severe condition,...